These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25829295)

  • 1. Pain characteristics and analgesic treatment in an aged adult population: a 4-week retrospective analysis of advanced cancer patients followed at home.
    Mercadante S; Aielli F; Masedu F; Valenti M; Ficorella C; Porzio G
    Drugs Aging; 2015 Apr; 32(4):315-20. PubMed ID: 25829295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of symptoms and symptomatic treatment in adults and the aged population: a retrospective analysis of advanced cancer patients followed at home.
    Mercadante S; Aielli F; Masedu F; Valenti M; Verna L; Mercadante A; Porzio G
    Curr Med Res Opin; 2016 May; 32(5):893-8. PubMed ID: 26824824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age differences in the last week of life in advanced cancer patients followed at home.
    Mercadante S; Aielli F; Masedu F; Valenti M; Verna L; Porzio G
    Support Care Cancer; 2016 Apr; 24(4):1889-95. PubMed ID: 26471279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen.
    Mercadante S; Prestia G; Casuccio A
    Curr Med Res Opin; 2013 Nov; 29(11):1527-32. PubMed ID: 23869428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid switching in patients with advanced cancer followed at home. A retrospective analysis.
    Mercadante S; Valle A; Porzio G; Fusco F; Aielli F; Adile C; Casuccio A;
    J Pain Symptom Manage; 2013 Feb; 45(2):298-304. PubMed ID: 23102561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fentanyl buccal tablet.
    Messina J; Darwish M; Fine PG
    Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses.
    Mercadante S; Gatti A; Porzio G; Lo Presti C; Aielli F; Adile C; Casuccio A
    Curr Med Res Opin; 2012 Jun; 28(6):963-8. PubMed ID: 22480130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics.
    Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
    J Opioid Manag; 2010; 6(2):97-108. PubMed ID: 20481174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
    Kosugi T; Hamada S; Takigawa C; Shinozaki K; Kunikane H; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
    J Pain Symptom Manage; 2014 Jun; 47(6):990-1000. PubMed ID: 24099893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
    Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A;
    Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian variation of breakthrough pain in cancer patients.
    Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
    Eur J Pain; 2013 Feb; 17(2):264-70. PubMed ID: 22715071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart.
    Thronæs M; Raj SX; Brunelli C; Almberg SS; Vagnildhaug OM; Bruheim S; Helgheim B; Kaasa S; Knudsen AK
    Support Care Cancer; 2016 Jun; 24(6):2565-74. PubMed ID: 26712631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain intensity as prognostic factor in cancer pain management.
    Mercadante S; Porzio G; Adile C; Aielli F; Cortegiani A; Caruselli A; Casuccio A
    Pain Pract; 2015 Jan; 15(1):E1-8. PubMed ID: 25387823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
    Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough pain in patients referred to pain clinics: the Italian pain network retrospective study.
    Gatti A; Mediati RD; Reale C; Cuomo A; Vellucci R; Russo G; Costantini A; Canneti A; Luzi M; Mammucari M; Sabato AF
    Adv Ther; 2012 May; 29(5):464-72. PubMed ID: 22622488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen.
    Mercadante S; Prestia G; Adile C; Casuccio A
    J Pain; 2014 Jun; 15(6):602-7. PubMed ID: 24561001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
    Portenoy RK; Messina J; Xie F; Peppin J
    Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of opioid rotation in the control of cancer pain: the ROTODOL study.
    González-Barboteo J; Alentorn XG; Manuel FA; Candel VA; Eito MA; Sánchez-Magro I; Álvarez MN; Martín FJ; Porta-Sales J
    J Opioid Manag; 2014; 10(6):395-403. PubMed ID: 25531957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.